|
Investigation: visual inspection: the following observations were made during the visual inspection: - the progav 2.0 valve was not correct connected - deposits on the catheter permeability test: the test showed that the progav 2.0 shunt system and all other parts are permeable.Computer control test: the computer controlled test showed the opening pressure of the progav 2.0, at a reference flow rate of 20 ml/h in a horizontal position of the valve, to be 7.50 cmh2o.This is not within the specified tolerance of 2 cmh2o ± 3 cmh2o.An applied pressure of 2 cmh2o, with the device in the horizontal position is expected to have a resultant pressure of 2 cmh2o ± 3 cmh2o.According to our results, showed a presence of a slowed outflow.Additionally, the shuntassistant was tested according to standard procedure in the vertical position of the valve.At a fixed opening pressure of 20 cmh2o in the vertical position, a pressure of 20 cmh2o +4/-2 cmh2o is expected.The results indicated that at a reference flow of 20 ml/h in the vertical position, the shuntassistant had a pressure of 18.92 cmh2o.This is within the specified tolerance of 20 cmh2o +4/-2 cmh2o.Adjustability test: the progav 2.0 was found to be adjustable to all pressure settings.Braking force and brake function test: the braking force of the progav 2.0 was within the specified tolerance and the brake function operated as expected.Internal inspection of product: after dismantling of the valves, some deposits were found in both valves.Results: based on our investigation results, we can identify a slowed outflow in the shunt system.The malfunction of the adjustability could not confirm during the investigation.We are assuming that the deposits detected within the valves have caused the functional impairment.Deposits caused by natural substances in the cerebrospinal fluid, such as protein, blood or tissue particles, are among the known and unavoidable risks and side effects of hydrocephalus therapy.Small amounts of non-visible deposits/proteins might compromise the integrity of the valve.We can exclude a defect at the time of release.The shunt system met all specifications of the final inspection when released from christoph miethke gmbh & co.Kg.This case is connected to medwatch # 3004721439-2021-00074.
|